Singulex Inc., the privately held immunodiagnostics company based in Alameda, CA, is close to market launch of its Clarity in vitro diagnostic system. The fully automated platform is designed to bring the benefits of the company’s Single Molecule Counting (SMC) technology to hospital and reference laboratories.
Singulex bills its SMC technology as “the backbone of next generation immunodiagnostics, because it offers “unprecedented sensitivity and dynamic range...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?